SG Americas Securities’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $133K | Sell |
8,795
-24,227
| -73% | -$423K | ﹤0.01% | 2979 |
|
|
2026
Q1 | $633K | Sell |
33,022
-28,936
| -47% | -$629K | ﹤0.01% | 2048 |
|
|
2025
Q4 | $1.36M | Sell |
61,958
-1,093
| -2% | -$19.7K | ﹤0.01% | 1776 |
|
|
2025
Q3 | $765K | Buy |
63,051
+35,291
| +127% | +$478K | ﹤0.01% | 1719 |
|
|
2025
Q2 | $517K | Buy |
27,760
+11,407
| +70% | +$226K | ﹤0.01% | 1654 |
|
|
2025
Q1 | $313K | Buy |
16,353
+12,847
| +366% | +$376K | ﹤0.01% | 2179 |
|
|
2024
Q4 | $126K | Sell |
3,506
-5,483
| -61% | -$185K | ﹤0.01% | 2553 |
|
|
2024
Q3 | $381K | Sell |
8,989
-68,658
| -88% | -$2.91M | ﹤0.01% | 1936 |
|
|
2024
Q2 | $3.13M | Sell |
77,647
-69,965
| -47% | -$2.92M | 0.02% | 757 |
|
|
2024
Q1 | $5.23M | Buy |
+147,612
| New | +$3.95M | 0.03% | 533 |
|
|
2023
Q4 | – | Sell |
-23,510
| Closed | -$488K | – | 3445 |
|
|
2023
Q3 | $488K | Buy |
23,510
+9,751
| +71% | +$268K | 0.01% | 1792 |
|
|
2023
Q2 | $338K | Buy |
13,759
+2,968
| +28% | +$95.5K | ﹤0.01% | 1562 |
|
|
2023
Q1 | $438K | Sell |
10,791
-8,035
| -43% | -$333K | 0.01% | 1821 |
|
|
2022
Q4 | $846K | Buy |
18,826
+14,321
| +318% | +$648K | 0.01% | 1093 |
|
|
2022
Q3 | $216K | Buy |
4,505
+1,882
| +72% | +$103K | ﹤0.01% | 2263 |
|
|
2022
Q2 | $155K | Sell |
2,623
-45,104
| -95% | -$3.7M | ﹤0.01% | 2847 |
|
|
2022
Q1 | $5.55M | Buy |
47,727
+22,183
| +87% | +$2.59M | 0.04% | 371 |
|
|
2021
Q4 | $3.85M | Sell |
25,544
-4,092
| -14% | -$552K | 0.02% | 620 |
|
|
2021
Q3 | $3.54M | Sell |
29,636
-28,897
| -49% | -$3.18M | 0.02% | 782 |
|
|
2021
Q2 | $5.7M | Buy |
58,533
+17,595
| +43% | +$1.57M | 0.03% | 539 |
|
|
2021
Q1 | $3.61M | Sell |
40,938
-11,043
| -21% | -$1.03M | 0.02% | 689 |
|
|
2020
Q4 | $4.97M | Buy |
51,981
+39,962
| +332% | +$4.12M | 0.03% | 510 |
|
|
2020
Q3 | $1.36M | Buy |
12,019
+9,910
| +470% | +$1.04M | 0.01% | 1004 |
|
|
2020
Q2 | $209K | Sell |
2,109
-19,684
| -90% | -$1.57M | ﹤0.01% | 2828 |
|
|
2020
Q1 | $1.4M | Buy |
21,793
+5,837
| +37% | +$409K | 0.01% | 1051 |
|
|
2019
Q4 | $951K | Buy |
15,956
+1,603
| +11% | +$98.9K | 0.01% | 1296 |
|
|
2019
Q3 | $847K | Buy |
14,353
+11,990
| +507% | +$765K | 0.01% | 1502 |
|
|
2019
Q2 | $152K | Sell |
2,363
-704
| -23% | -$45.4K | ﹤0.01% | 2577 |
|
|
2019
Q1 | $195K | Sell |
3,067
-4,511
| -60% | -$237K | ﹤0.01% | 2594 |
|
|
2018
Q4 | $288K | Sell |
7,578
-22,012
| -74% | -$777K | ﹤0.01% | 2196 |
|
|
2018
Q3 | $1.27M | Buy |
+29,590
| New | +$1.03M | 0.01% | 1514 |
|
Other funds holding TNDM
SC
FLAM
GKIM
PIM
SG Americas Securities's TNDM Position: Q2 2026 in Review
SG Americas Securities reduced its Tandem Diabetes Care (TNDM) stake by 73% in Q2 2026, selling an estimated $423K and leaving 8,795 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #2979.
SG Americas Securities first reported a position in TNDM in Q3 2018 and has held it in 31 quarters since. The position peaked at $5.7M in Q2 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- SG Americas Securities held 8,795 shares of Tandem Diabetes Care worth $133K as of Q2 2026.
- SG Americas Securities sold 24,227 Tandem Diabetes Care shares in Q2 2026, an estimated $423K.
- Tandem Diabetes Care made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2979 holding.
- SG Americas Securities first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 31 quarters since.
- SG Americas Securities's Tandem Diabetes Care position peaked at $5.7M in Q2 2021.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.